← All drug classes
Drug class · FAERS comparison

Thiazide-like Diuretic side effects compared: 3 drugs, 40,523 FDA adverse event reports

Class as assigned in the FDA label (Established Pharmacologic Class) · data 2026-09-14
How to read this page. Report counts are not incidence rates: a drug with more reports is usually older, more widely used or more publicised, not more dangerous. Signals are screened against each product's FDA label on its own page; a term flagged across most of a class usually reflects the shared mechanism or the shared patient population.

Members

DrugFAERS reportsSeriousDeath outcomeBoxed warningTop labeled signalsUnlabeled (unassessed)
Indapamide17,81693%1,137–Hyponatraemia; Central nervous system lupusButterfly rash; Lupus nephritis
Chlorthalidone11,54263%690–Chronic kidney disease; Hyponatraemia; Blood potassium decreasedEnd stage renal disease; Cardiac murmur
Metolazone11,16579%2,203–Metabolic alkalosisEnd stage renal disease; Fluid overload

Class-wide signals (flagged in at least 2 of 3 members)

ReactionMembers flaggedMedian PRRReports (sum)In label
Chronic kidney disease-mineral and bone disorder2/356.6640/2 members' labels
Nephrogenic anaemia2/348.92400/2 members' labels
Hyperparathyroidism secondary2/345.91221/2 members' labels
Renal artery stenosis2/331.0620/2 members' labels
Metabolic alkalosis2/327.8472/2 members' labels
Rebound acid hypersecretion2/325.7840/2 members' labels
End stage renal disease2/322.14310/2 members' labels
Hyponatraemia2/319.01,6162/2 members' labels

Member-specific signals (flagged in exactly one drug)

No strong single-member signals (n ≥ 50) in this class.

Common questions

Which thiazide-like diuretic has the most FDA adverse event reports?

Indapamide has the most FAERS co-reports in this class (17,816), followed by Chlorthalidone (11,542). Report volume tracks how widely and how long a drug has been used, and how much attention it has had, far more than its risk.

Which side effects are shared across thiazide-like diuretic drugs?

Reaction terms flagged in at least half of the 3 members include chronic kidney disease-mineral and bone disorder, nephrogenic anaemia, hyperparathyroidism secondary, renal artery stenosis, metabolic alkalosis. A term shared across a class usually reflects the shared mechanism (or the shared patient population) rather than one product.

Does a FAERS signal mean the drug causes the reaction?

No. These are disproportionality signals from voluntary reports with no denominator. Each is screened against the FDA label (known vs unlabeled) on the drug pages; causality needs temporality, dose-response, plausibility and trial or cohort evidence.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, seriousness and death counts from openFDA count queries. Generated 2026-10-08. Not medical advice.